Eickel V et al. |
Emergence of respiratory Streptococcus agalactiae isolates in cystic fibrosis patients. |
2009 |
PLoS ONE |
pmid:19247473
|
Yonezawa H et al. |
Impact of Helicobacter pylori biofilm formation on clarithromycin susceptibility and generation of resistance mutations. |
2013 |
PLoS ONE |
pmid:24039906
|
Jakobsson HE et al. |
Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. |
2010 |
PLoS ONE |
pmid:20352091
|
Juste RA et al. |
On the prevalence of M. avium subspecies paratuberculosis DNA in the blood of healthy individuals and patients with inflammatory bowel disease. |
2008 |
PLoS ONE |
pmid:18596984
|
Kim BJ et al. |
Discovery of a novel hsp65 genotype within Mycobacterium massiliense associated with the rough colony morphology. |
2012 |
PLoS ONE |
pmid:22693637
|
Shin SH et al. |
Helicobacter pylori Eradication Prevents Metachronous Gastric Neoplasms after Endoscopic Resection of Gastric Dysplasia. |
2015 |
PLoS ONE |
pmid:26580072
|
Desai S et al. |
The Epidemiology of Invasive Haemophilus influenzae Non-Serotype B Disease in Ontario, Canada from 2004 to 2013. |
2015 |
PLoS ONE |
pmid:26569613
|
Rubio M et al. |
Inducible and Acquired Clarithromycin Resistance in the Mycobacterium abscessus Complex. |
2015 |
PLoS ONE |
pmid:26448181
|
Makobongo MO et al. |
In vitro characterization of the anti-bacterial activity of SQ109 against Helicobacter pylori. |
2013 |
PLoS ONE |
pmid:23935905
|
Chauffour A et al. |
Sterilizing Activity of Fully Oral Intermittent Regimens against Mycobacterium Ulcerans Infection in Mice. |
2016 |
PLoS Negl Trop Dis |
pmid:27755552
|
Converse PJ et al. |
Efficacy of Rifampin Plus Clofazimine in a Murine Model of Mycobacterium ulcerans Disease. |
2015 |
PLoS Negl Trop Dis |
pmid:26042792
|
Friedman ND et al. |
Mycobacterium ulcerans disease: experience with primary oral medical therapy in an Australian cohort. |
2013 |
PLoS Negl Trop Dis |
pmid:23875050
|
Cowan R et al. |
Mycobacterium ulcerans treatment--can antibiotic duration be reduced in selected patients? |
2015 |
PLoS Negl Trop Dis |
pmid:25658304
|
Gopinath K and Singh S |
Non-tuberculous mycobacteria in TB-endemic countries: are we neglecting the danger? |
2010 |
PLoS Negl Trop Dis |
pmid:20436962
|
Vinh H et al. |
A multi-center randomized trial to assess the efficacy of gatifloxacin versus ciprofloxacin for the treatment of shigellosis in Vietnamese children. |
2011 |
PLoS Negl Trop Dis |
pmid:21829747
|
Almeida D et al. |
Activities of rifampin, Rifapentine and clarithromycin alone and in combination against mycobacterium ulcerans disease in mice. |
2011 |
PLoS Negl Trop Dis |
pmid:21245920
|
Hobbie SN et al. |
Genetic reconstruction of protozoan rRNA decoding sites provides a rationale for paromomycin activity against Leishmania and Trypanosoma. |
2011 |
PLoS Negl Trop Dis |
pmid:21629725
|
Trunck LA et al. |
Molecular basis of rare aminoglycoside susceptibility and pathogenesis of Burkholderia pseudomallei clinical isolates from Thailand. |
2009 |
PLoS Negl Trop Dis |
pmid:19771149
|
Gordon CL et al. |
All-oral antibiotic treatment for buruli ulcer: a report of four patients. |
2010 |
PLoS Negl Trop Dis |
pmid:21152060
|
O'Brien DP et al. |
Successful outcomes with oral fluoroquinolones combined with rifampicin in the treatment of Mycobacterium ulcerans: an observational cohort study. |
2012 |
PLoS Negl Trop Dis |
pmid:22272368
|
Connolly LE et al. |
Why is long-term therapy required to cure tuberculosis? |
2007 |
PLoS Med. |
pmid:17388672
|
Corrales-Medina VF et al. |
Cardiac complications in patients with community-acquired pneumonia: a systematic review and meta-analysis of observational studies. |
2011 |
PLoS Med. |
pmid:21738449
|
Skalet AH et al. |
Antibiotic selection pressure and macrolide resistance in nasopharyngeal Streptococcus pneumoniae: a cluster-randomized clinical trial. |
2010 |
PLoS Med. |
pmid:21179434
|
Letek M et al. |
The genome of a pathogenic rhodococcus: cooptive virulence underpinned by key gene acquisitions. |
2010 |
PLoS Genet. |
pmid:20941392
|
Balcan D et al. |
Modeling the critical care demand and antibiotics resources needed during the Fall 2009 wave of influenza A(H1N1) pandemic. |
2009 |
PLoS Curr |
pmid:20029670
|
Fouts DE et al. |
Major structural differences and novel potential virulence mechanisms from the genomes of multiple campylobacter species. |
2005 |
PLoS Biol. |
pmid:15660156
|
Matsukawa Y et al. |
Long term changes in platelet counts after H. pylori eradication in non-ITP patients. |
2010 |
Platelets |
pmid:20849211
|
Matsukawa Y et al. |
Helicobacter pylori eradication reduces platelet count in patients without idiopathic thrombocytopenic purpura. |
2007 |
Platelets |
pmid:17365854
|
Lee D et al. |
Localized Mycobacterium avium-intracellulare mastitis in an immunocompetent woman with silicone breast implants. |
1995 |
Plast. Reconstr. Surg. |
pmid:7809228
|
Hess CL et al. |
Mycobacterium marinum infections of the upper extremity. |
2005 |
Plast. Reconstr. Surg. |
pmid:15731663
|
Dantas da Silva LL et al. |
Antibacterial activity of a stearic acid derivative from Stemodia foliosa. |
2002 |
Planta Med. |
pmid:12494347
|
Kwak HM et al. |
The efficacy of cefazolin plus macrolide (erythromycin or clarithromycin) versus cefazolin alone in neonatal morbidity and placental inflammation for women with preterm premature rupture of membranes. |
2013 |
Placenta |
pmid:23465535
|
|
MAC management. |
1996 |
PI Perspect |
pmid:11363967
|
Cheng B |
Preventing opportunistic infections. |
1995 |
PI Perspect |
pmid:11362422
|
Liu WH et al. |
In vitro anti-Helicobacter pylori activity of diallyl sulphides and protocatechuic acid. |
2008 |
Phytother Res |
pmid:17705145
|
Nostro A et al. |
Effects of combining extracts (from propolis or Zingiber officinale) with clarithromycin on Helicobacter pylori. |
2006 |
Phytother Res |
pmid:16521108
|
Lawal TO et al. |
Combination studies of Eucalyptus torelliana F. Muell. leaf extracts and clarithromycin on Helicobacter pylori. |
2012 |
Phytother Res |
pmid:22318891
|
Safak B et al. |
In vitro anti-Helicobacter pylori activity of usnic acid. |
2009 |
Phytother Res |
pmid:19367654
|
Stege PW et al. |
Antimicrobial activity of aqueous extracts of Larrea divaricata Cav (jarilla) against Helicobacter pylori. |
2006 |
Phytomedicine |
pmid:17085295
|
Dabos KJ et al. |
The effect of mastic gum on Helicobacter pylori: a randomized pilot study. |
2010 |
Phytomedicine |
pmid:19879118
|
Celik H and Ayar A |
Clarithromycin inhibits myometrial contractions in isolated human myometrium independent of stimulus. |
2002 |
Physiol Res |
pmid:12234115
|
Kim PK and Dorshimer GW |
Case report: peptic ulcer disease in a professional athlete. |
2009 |
Phys Sportsmed |
pmid:20048520
|
Guo D et al. |
The cardiotoxicity of macrolides: a systematic review. |
2010 |
Pharmazie |
pmid:21038838
|
Valizadeh H et al. |
Antibacterial activity of clarithromycin loaded PLGA nanoparticles. |
2012 |
Pharmazie |
pmid:22393833
|
Togami K et al. |
Transport characteristics of clarithromycin, azithromycin and telithromycin, antibiotics applied for treatment of respiratory infections, in Calu-3 cell monolayers as model lung epithelial cells. |
2012 |
Pharmazie |
pmid:22764569
|
Hamdan II |
Comparative in vitro investigations of the interaction between some macrolides and Cu(II), Zn(II) and Fe(II). |
2003 |
Pharmazie |
pmid:12685822
|
Lohitnavy M et al. |
Pharmacokinetic and bloequivalence studies of generic clarithromycin tablets in healthy male volunteers. |
2003 |
Pharmazie |
pmid:12622260
|
Chadha R et al. |
Quantitative analysis of in vitro compatibility of binary and ternary mixtures of nitroimidazole and macrolides in combination with omeprazole using a calorimetric technique. |
2007 |
Pharmazie |
pmid:17557738
|
Najib MM et al. |
Cost-effectiveness of sparfloxacin compared with other oral antimicrobials in outpatient treatment of community-acquired pneumonia. |
2000 |
Pharmacotherapy |
pmid:10772376
|
Mertl SL |
The role of clarithromycin in the prophylaxis of disseminated Mycobacterium avium-intracellulare infection in patients with AIDS. |
1996 May-Jun |
Pharmacotherapy |
pmid:8726597
|
Mor N et al. |
Accumulation of clarithromycin in macrophages infected with Mycobacterium avium. |
1994 Jan-Feb |
Pharmacotherapy |
pmid:8159593
|
Auclair B et al. |
Potential interaction between itraconazole and clarithromycin. |
1999 |
Pharmacotherapy |
pmid:10600094
|
Khamaisi M and Leitersdorf E |
Severe hypoglycemia from clarithromycin-repaglinide drug interaction. |
2008 |
Pharmacotherapy |
pmid:18447665
|
Otsuka SH |
Severe hypoglycemia from Helicobacter pylori triple-drug therapy and insulin detemir drug interaction. |
2013 |
Pharmacotherapy |
pmid:23471710
|
Nicholson SC et al. |
Antimicrobial-associated acute hepatitis. |
2002 |
Pharmacotherapy |
pmid:12066973
|
Gaylor AS and Reilly JC |
Therapy with macrolides in patients with cystic fibrosis. |
2002 |
Pharmacotherapy |
pmid:11837560
|
Adelglass J et al. |
A multicenter, investigator-blinded, randomized comparison of oral levofloxacin and oral clarithromycin in the treatment of acute bacterial sinusitis. |
1998 Nov-Dec |
Pharmacotherapy |
pmid:9855324
|
Kang-Birken SL and Prichard JG |
Mycobacterium szulgai in a patient with advanced acquired immunodeficiency syndrome: an unusual pathogen with unusual multidrug resistance. |
2006 |
Pharmacotherapy |
pmid:17064210
|
Guerriero SE et al. |
Two cases of clarithromycin-induced digoxin toxicity. |
1997 Sep-Oct |
Pharmacotherapy |
pmid:9324195
|
McConnell SA and Amsden GW |
Review and comparison of advanced-generation macrolides clarithromycin and dirithromycin. |
1999 |
Pharmacotherapy |
pmid:10212011
|
Molden E and Andersson KS |
Simvastatin-associated rhabdomyolysis after coadministration of macrolide antibiotics in two patients. |
2007 |
Pharmacotherapy |
pmid:17381388
|
Oberg KC |
Delayed elevation of international normalized ratio with concurrent clarithromycin and warfarin therapy. |
1998 Mar-Apr |
Pharmacotherapy |
pmid:9545160
|
Shin J et al. |
Effect of cytochrome P450 3A5 genotype on atorvastatin pharmacokinetics and its interaction with clarithromycin. |
2011 |
Pharmacotherapy |
pmid:21950641
|
Stein GE et al. |
A preliminary study of clarithromycin versus doxycycline in the treatment of nongonococcal urethritis and mucopurulent cervicitis. |
1995 Nov-Dec |
Pharmacotherapy |
pmid:8602379
|
Stein GE and Schooley S |
Serum bactericidal activity of extended-release clarithromycin against macrolide-resistant strains of Streptococcus pneumoniae. |
2002 |
Pharmacotherapy |
pmid:12013358
|
Sketris IS et al. |
Possible role of the intestinal P-450 enzyme system in a cyclosporine-clarithromycin interaction. |
1996 Mar-Apr |
Pharmacotherapy |
pmid:8820476
|
Legendre DP et al. |
Hansen's disease (Leprosy): current and future pharmacotherapy and treatment of disease-related immunologic reactions. |
2012 |
Pharmacotherapy |
pmid:22392826
|
Schulz-Du Bois C et al. |
Major increase of quetiapine steady-state plasma concentration following co-administration of clarithromycin: confirmation of the pharmacokinetic interaction potential of quetiapine. |
2008 |
Pharmacopsychiatry |
pmid:19067264
|
Kitano M et al. |
Effects of clarithromycin and dexamethasone on mucus production in isografted rat trachea. |
2011 |
Pharmacology |
pmid:21228611
|
Jokinen MJ et al. |
Effect of clarithromycin and itraconazole on the pharmacokinetics of ropivacaine. |
2001 |
Pharmacol. Toxicol. |
pmid:11322176
|
Yamamoto K et al. |
Clarithromycin prevents human respiratory syncytial virus-induced airway epithelial responses by modulating activation of interferon regulatory factor-3. |
2016 |
Pharmacol. Res. |
pmid:27468646
|
Calabresi L et al. |
Pharmacokinetic interactions between omeprazole/pantoprazole and clarithromycin in health volunteers. |
2004 |
Pharmacol. Res. |
pmid:14998561
|
Pauwels O |
Factors contributing to carbamazepine-macrolide interactions. |
2002 |
Pharmacol. Res. |
pmid:12030792
|
Woo PC et al. |
Clarithromycin attenuates cyclophosphamide-induced mucositis in mice. |
2000 |
Pharmacol. Res. |
pmid:10753551
|
Marjanović N et al. |
Macrolide antibiotics broadly and distinctively inhibit cytokine and chemokine production by COPD sputum cells in vitro. |
2011 |
Pharmacol. Res. |
pmid:21315154
|
Woo PC et al. |
Clarithromycin attenuates the inflammatory response induced by surgical trauma in a guinea pig model. |
1999 |
Pharmacol. Res. |
pmid:10051377
|
Karczewska E et al. |
Primary and secondary clarithromycin, metronidazole, amoxicillin and levofloxacin resistance to Helicobacter pylori in southern Poland. |
2011 |
Pharmacol Rep |
pmid:21857091
|
Szałek E et al. |
Sunitinib in combination with clarithromycin or azithromycin - is there a risk of interaction or not? |
2012 |
Pharmacol Rep |
pmid:23406766
|
Fohner AE et al. |
PharmGKB summary: Macrolide antibiotic pathway, pharmacokinetics/pharmacodynamics. |
2017 |
Pharmacogenet. Genomics |
pmid:28146011
|
Allen LaPointe NM et al. |
Frequency of high-risk use of QT-prolonging medications. |
2006 |
Pharmacoepidemiol Drug Saf |
pmid:16178046
|
Quach C et al. |
Effectiveness of amoxicillin, azithromycin, cefprozil and clarithromycin in the treatment of acute otitis media in children: a population-based study. |
2005 |
Pharmacoepidemiol Drug Saf |
pmid:15386697
|
Galatti L et al. |
Co-prescriptions with itraconazole and fluconazole as a signal for possible risk of drug-drug interactions: a four-year analysis from Italian general practice. |
2007 |
Pharmacoepidemiol Drug Saf |
pmid:17323404
|
Corrao G et al. |
Generating signals of drug-adverse effects from prescription databases and application to the risk of arrhythmia associated with antibacterials. |
2005 |
Pharmacoepidemiol Drug Saf |
pmid:15390219
|
Drinkard CR et al. |
Postmarketing surveillance of medications and pregnancy outcomes: clarithromycin and birth malformations. |
2000 |
Pharmacoepidemiol Drug Saf |
pmid:11338912
|
Bérard A et al. |
Use of macrolides during pregnancy and the risk of birth defects: a population-based study. |
2015 |
Pharmacoepidemiol Drug Saf |
pmid:26513406
|
Craig AM et al. |
Decision analysis of Helicobacter pylori eradication therapy using omeprazole with either clarithromycin or amoxicillin. |
1996 |
Pharmacoeconomics |
pmid:10160472
|
Agro K et al. |
Cost effectiveness in Canada of a multidrug prepackaged regimen (Hp-PAC)+ for Helicobacter pylori eradication. |
2001 |
Pharmacoeconomics |
pmid:11596835
|
Plosker GL and Figgitt DP |
Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus. |
2004 |
Pharmacoeconomics |
pmid:15099124
|
Ufuk A et al. |
In Vitro Assessment of Uptake and Lysosomal Sequestration of Respiratory Drugs in Alveolar Macrophage Cell Line NR8383. |
2015 |
Pharm. Res. |
pmid:26224396
|
Dimer F et al. |
Inhalable Clarithromycin Microparticles for Treatment of Respiratory Infections. |
2015 |
Pharm. Res. |
pmid:26113237
|
Vehring R |
Pharmaceutical particle engineering via spray drying. |
2008 |
Pharm. Res. |
pmid:18040761
|
Kita T et al. |
CYP2C19 genotype related effect of omeprazole on intragastric pH and antimicrobial stability. |
2001 |
Pharm. Res. |
pmid:11465416
|
Haghi M et al. |
Immunomodulatory effects of a low-dose clarithromycin-based macrolide solution pressurised metered dose inhaler. |
2015 |
Pharm. Res. |
pmid:25537341
|
Lu MY et al. |
A polymer carrier system for taste masking of macrolide antibiotics. |
1991 |
Pharm. Res. |
pmid:1829521
|
Rotsch TD et al. |
Determination of clarithromycin as a contaminant on surfaces by high-performance liquid chromatography using electrochemical detection. |
1991 |
Pharm. Res. |
pmid:1833731
|
Meng Y et al. |
Multi-functional Liposomes Enhancing Target and Antibacterial Immunity for Antimicrobial and Anti-Biofilm Against Methicillin-Resistant Staphylococcus aureus. |
2016 |
Pharm. Res. |
pmid:26666773
|
Takeuchi T et al. |
Establishment and characterization of the transformants stably-expressing MDR1 derived from various animal species in LLC-PK1. |
2006 |
Pharm. Res. |
pmid:16779700
|
Rose WE et al. |
Prevention of biofilm formation by methacrylate-based copolymer films loaded with rifampin, clarithromycin, doxycycline alone or in combination. |
2015 |
Pharm. Res. |
pmid:24934663
|
Becker ML et al. |
Determinants of potential drug-drug interaction associated dispensing in community pharmacies in the Netherlands. |
2007 |
Pharm World Sci |
pmid:17187223
|
Sancar M et al. |
Pharmacoeconomic comparison of Helicobacter pylori eradication regimens. |
2006 |
Pharm World Sci |
pmid:17066247
|